In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models

Por Schleiferböck, Sarah, Scheurer, Christian, Ihara, Masataka, Itoh, Isamu, Bathurst, Ian, Burrows, Jeremy N, Fantauzzi, Pascal, Lotharius, Julie, Charman, Susan A, Morizzi, Julia, Shackleford, David M, White, Karen L, Brun, Reto, Wittlin, Sergio
Publicado em 2013

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

Por Yuthavong, Yongyuth, Tarnchompoo, Bongkoch, Vilaivan, Tirayut, Chitnumsub, Penchit, Kamchonwongpaisan, Sumalee, Charman, Susan A., McLennan, Danielle N., White, Karen L., Vivas, Livia, Bongard, Emily, Thongphanchang, Chawanee, Taweechai, Supannee, Vanichtanankul, Jarunee, Rattanajak, Roonglawan, Arwon, Uthai, Fantauzzi, Pascal, Yuvaniyama, Jirundon, Charman, William N., Matthews, David
Publicado em 2012

Identification of inhibitors for putative malaria drug targets amongst novel antimalarial compounds

Por Crowther, Gregory J., Napuli, Alberto J., Gilligan, James H., Gagaring, Kerstin, Borboa, Rachel, Francek, Carolyn, Chen, Zhong, Dagostino, Eleanor F., Stockmyer, Justin B., Wang, Yu, Rodenbough, Philip P., Castaneda, Lisa J., Leibly, David J., Bhandari, Janhavi, Gelb, Michael H., Brinker, Achim, Engels, Ingo, Taylor, Jennifer, Chatterjee, Arnab K., Fantauzzi, Pascal, Glynne, Richard J., Van Voorhis, Wesley C., Kuhen, Kelli L.
Publicado em 2010